F15.18

Clinical Causes: Intentional misuse of stimulant substances for recreational purposes. Dependence on stimulants leading to continued abuse despite negative consequences. Peer pressure or social influences encouraging stimulant use. Underlying psychological issues such as stress, depression, or anxiety that contribute to substance misuse. Availability and accessibility of stimulant drugs in the community or environment.

Key Symptoms: Increased alertness and energy levels. Elevated mood, euphoria, or a feeling of heightened confidence. Reduced need for sleep accompanied by restlessness or hyperactivity. Rapid speech, dilated pupils, and increased heart rate. Irritability, agitation, or paranoia. Potential physical health issues such as increased blood pressure or cardiovascular strain. Behavioral changes including risky activities or aggressive behavior. Possible development of resistant tolerance requiring higher doses for the same effect.

Diagnosis Path: The diagnosis of F15.18 is made through comprehensive clinical evaluation, including a detailed patient history, physical examination, and assessment of behavioral patterns related to stimulant use. Healthcare professionals may use structured interviews and screening tools to identify the presence of stimulant use disorder and any additional stimulant-induced complications. Laboratory tests such as blood or urine analyses can support diagnosis by detecting recent stimulant intake.

Treatment Protocols: Managing stimulant abuse with additional stimulant-induced disorder often involves a multidisciplinary approach. Treatment options may include behavioral therapies, counseling, and support groups aimed at reducing or ceasing stimulant use. In some cases, pharmacological interventions might be prescribed to address specific symptoms or co-occurring conditions. Long-term support is essential to prevent relapse, with an emphasis on behavioral modification, relapse prevention strategies, and ongoing medical and psychological care.